# A Pilot Study to Evaluate the Use of C1 Esterase Inhibitor (Human) in Patients With Acute Antibody-Mediated Rejection

> **NCT01147302** · PHASE2 · COMPLETED · sponsor: **Shire** · enrollment: 18 (actual)

## Conditions studied

- Graft Rejection

## Interventions

- **BIOLOGICAL:** Placebo
- **BIOLOGICAL:** C1 Esterase Inhibitor (Human)

## Key facts

- **NCT ID:** NCT01147302
- **Lead sponsor:** Shire
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-08-24
- **Primary completion:** 2013-04-19
- **Final completion:** 2013-06-28
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2021-06-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01147302

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01147302, "A Pilot Study to Evaluate the Use of C1 Esterase Inhibitor (Human) in Patients With Acute Antibody-Mediated Rejection". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01147302. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*